Pine Bark Extract Boosts Heart Health
Pine Bark Extract Boost Diabetics’ Heart Health May 13, 2008
Supplements of extracts from French maritime pine bark reduce blood pressure and the use of blood pressure medication among diabetics, concludes results from a new study.
Blood pressure control was achieved in 58 per cent of study participants, and a halving of the use of medication, among 48 participants randomly assigned to daily supplements of pine bark extract or placebo for 12 weeks. The results of the new study, published in the May issue of the journal Nutrition Research, is of particular importance for diabetics who are reportedly two to four times more likely to suffer from heart disease than non-diabetics “”These data confirm the hypothesis that pine bark extract improves diabetes control, reduces antihypertensive medicine use, and may favour a reduction in cardiovascular disease risk in individuals with type 2 diabetes,”" wrote lead author Sherma Zibadi from the University of Arizona. Indeed, previous studies have reported potential health benefits for the extract, including hypertension, asthma, chronic venous insufficiency, osteoarthritis, deep vein thrombosis, diabetes management, and diabetic leg ulcers. The new study recruited diabetic subjects with an average age of 60 and randomly assigned them to receive daily supplements of pine bark extract (125 mg) or placebo for 12 weeks in a randomized, double-blind, placebo-controlled trial with parallel-group design. All subjects were receiving pharmaceutical anti-hypertension treatment (angiotensin- converting enzyme [ACE] inhibitors). At the end of the study, Zibadi and co-workers report that 58.3 per cent of subjects in the pine bark extract group experienced blood pressure control, defined as attaining a stable systolic blood pressure, compared to 20.8 per cent in the placebo group. Moreover, use of ACE inhibitors was reduced by 50 per cent in the group receiving the pine bark extract Improvements in measures of diabetes control were also recorded, with a 23.7 mg/dL reduction in fasting blood glucose levels in the pine bark extract group, compared to only 5.7 mg/dL in the placebo group. Improvements in LDL-cholesterol, a marker of cardiovascular health, were recorded in the pine bark extract-supplemented group. After eight and 12 weeks of supplementation, decreases of 11.6 and 12.7 mg/dL were observed, respectively, compared with placebo. Mechanism of Action In attempting to understand the benefits of the pine bark extract on cardiovascular health of the diabetics, the researchers noted that the blood pressure lowering effects may be due to a suppression of serum endothelin-1, a protein that restricts blood vessels and reported to be found in higher levels than normal in type 2 diabetics and hypertensives. On the other hand, the authors could not rule out the potential of an inhibitory effect on ACE, which could improve blood flow and subsequently blood pressure. Finally, other studies have reported a potential benefit from pine bark extract on the production of the potent vasodilator, nitric oxide (NO). Limitations About 26.5 million people are affected by diabetes in the European Union, United States, and Canada equal to four per cent of the total population. This figure is projected to increase to 40 million by 2030. In the US, there are over 20 million people with diabetes, equal to seven per cent of the population. The total costs are thought to be as much as $132 billion, with $92 billion being direct costs from medication, according to 2002 American Diabetes Association figures.
Source: Nutrition Research (Elsevier) May 2008, Volume 28, Issue 5, Pages 315-320 “”Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation”" Authors: S. Zibadi, P.J. Rohdewald, D. Park, R.R. Watson
Whole Grains Promote Healthy Weight
Bakers, Food makers and nutritionists are warning about the amazing popularity of the Atkins diet have a new tool in their fight against this food fad in a new study that reveals an inverse assocation between whole grains and weight gain.
It found that while women who ate a large amount of refined grain foods were more likely to be obese, those with the greatest whole grain consumption weighed less and are less likely to gain weight.
The study, published in November’s American Journal of Clinical Nutrition (vol 78, no 5, pp 920-927), investigated the relation between intake of dietary fibre and whole- or refined-grain products with weight gain over time.
They used a prospective cohort study on more than 74,000 US female nurses, aged 38-63 years in 1984 and free of known cardiovascular disease, cancer, and diabetes at baseline. Their dietary habits were assessed in 1984, 1986, 1990, and 1994 with validated food-frequency questionnaires.
Average weight, body mass index, long-term weight changes, and the odds ratio of developing obesity (BMI of 30) according to change in dietary intake were recorded.
The researchers from the Brigham and Women’s Hospital and Harvard Medical School found that women who consumed more whole grains consistently weighed less than women who consumed less whole grains.
Over 12 years, those with the greatest increase in intake of dietary fibre gained an average of 1.52 kg less than did those with the smallest increase in intake of dietary fibre independent of body weight at baseline and age.
Women in the highest quintile of dietary fibre intake had a 49 per cent lower risk of major weight gain than did women in the lowest quintile.
The team concludes that “”weight gain was inversely associated with the intake of high-fibre, whole-grain foods but positively related to the intake of refined-grain foods, which indicated the importance of distinguishing whole-grain products from refined-grain products to aid in weight control”".